Monday, August 04, 2025
New Review Highlights Significant Need for Comprehensive Care for Gun Violence Survivors
A new review article published in JAMA underscores the critical need for comprehensive long-term medical care for patients treated for firearm injuries, which has become an epidemic in the U.S. fueled by years of rising gun violence. More than 48,000 people died of firearm injuries in the U.S. in 2022, according to the Centers for Disease Control and Prevention with 120,000 suffering from gunshot wounds that they recover from.
Friday, July 25, 2025
New Research Simulates Cancer Cell Behavior
In the same vein as weather forecast models that predict developing storms, researchers now have developed a method to predict the cell activity in tissues over time. The new software combines genomics technologies with computational modeling to predict cell changes in behavior, such as communication between cells that could cause cancer cells to flourish.
Thursday, July 24, 2025
Preoperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery Without Increasing Patients’ Pain Level, New Research Shows
Preoperative counseling significantly reduced opioid use by patients undergoing anterior cruciate ligament (ACL) reconstruction, a common knee surgery, with no increase in pain following the procedure, according to new research by orthopaedic surgeons at the University of Maryland School of Medicine (UMSOM). The findings of the randomized clinical trial of 121 patients who had surgery at the University of Maryland Rehabilitation & Orthopaedic Institute (UM Rehab & Ortho) were published recently in the Journal of Bone and Joint Surgery.
Wednesday, July 23, 2025
Getting to Know: Elana Fertig, PhD, Director of the Institute for Genome Sciences at the University of Maryland School of Medicine
Elana J. Fertig, PhD, FAIMBE, joined the University of Maryland School of Medicine (UMSOM) in December 2024 as a Professor of Medicine and the new Director of the School’s Institute for Genome Sciences (IGS). She’s also the Associate Director for Quantitative Science in the Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).
Monday, July 21, 2025
Distinguished Physician-Scientist and Nationally Recognized Pulmonologist Roberto Machado, MD, Named Chair of the Department of Medicine at the University of Maryland School of Medicine
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Roberto Machado, MD, Chief of Pulmonary, Critical Care, Sleep, and Occupational Medicine at the Indiana University School of Medicine, has been appointed the new Chair of the Department of Medicine, the largest department at UMSOM with more than 400 full-time faculty members and 12 divisions. He will also serve as the Physician-In-Chief at the University of Maryland Medical Center.
Tuesday, July 15, 2025
Oldest Known Portrait of John Davidge Discovered in Defunct Fells Point Eatery
It could be called a finding of fate: The recent discovery of a more than 180-year-old painting of John Beale Davidge, MD, the founder of the University of Maryland School of Medicine. The portrait had been stashed in a storage closet at the former Bertha’s Mussels Restaurant in Fells Point.
Monday, July 14, 2025
UM School of Medicine Team Wins NIH TARGETED Challenge with Brain Genome Editing Technology
A team of researchers from the University of Maryland School of Medicine (UMSOM) recently won a $250,000 prize from the National Institutes of Health (NIH) to improve technologies for delivering genome editing tools to targeted cells in the body. They were one of four winners in a competition after successfully demonstrating a new technique to deliver genome editing biotechnology across the blood-brain barrier to brain cells in preclinical models.
Wednesday, July 09, 2025
University of Maryland School of Medicine Launches Groundbreaking Study on THC/CBD Therapy for Dementia-Related Agitation at End of Life
The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging to explore a potential treatment for agitation in patients with dementia nearing the end of life. The study focuses on an investigational oral drug, T2:C100, which contains the two active ingredients in cannabis: THC and CBD.
Monday, July 07, 2025
Dr. Deanna L. Kelly Named Director of the Maryland Psychiatric Research Center
Mark T. Gladwin, MD, Dean of the University of Maryland School of Medicine announced today that Deanna L. Kelly, PharmD, BCPP, a Professor of Psychiatry at the University of Maryland School of Medicine, has been named Director of the Maryland Psychiatric Research Center (MPRC), Dr. Kelly is a internationally recognized clinician-scientist specializing in the advancement of treatments for psychotic disorders and schizophrenia, after serving as Interim Director for three years.
Tuesday, July 01, 2025
UM School of Medicine Confocal Core Facility Offers Super-Resolution Microscopy to Enhance Imaging of Subcellular Structures
The UMSOM Confocal Microscopy Core facility is now offering researchers access to a state-of-the-art STED microscope that provides super-resolution imaging capabilities. It is the latest addition of an Abberior Facility Line STED microscope.